The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_004360.4(CDH1):c.532-1G>C

CA8129891

406644 (ClinVar)

Gene: CDH1
Condition: CDH1-related diffuse gastric and lobular breast cancer
Inheritance Mode: Autosomal dominant inheritance
UUID: 178322a8-a2f1-4290-9b3a-886e742bd5fa
Approved on: 2024-03-25
Published on: 2024-03-27

HGVS expressions

NM_004360.4:c.532-1G>C
NM_004360.4(CDH1):c.532-1G>C
NC_000016.10:g.68808692G>C
CM000678.2:g.68808692G>C
NC_000016.9:g.68842595G>C
CM000678.1:g.68842595G>C
NC_000016.8:g.67400096G>C
NG_008021.1:g.76401G>C
ENST00000261769.10:c.532-1G>C
ENST00000261769.9:c.532-1G>C
ENST00000422392.6:c.532-1G>C
ENST00000561751.1:c.299-1G>C
ENST00000562836.5:n.603-1G>C
ENST00000564676.5:n.814-1G>C
ENST00000564745.1:n.527-1G>C
ENST00000566510.5:c.531+125G>C
ENST00000566612.5:c.532-1G>C
ENST00000567320.1:n.42-1G>C
ENST00000611625.4:c.532-1G>C
ENST00000612417.4:c.532-1G>C
ENST00000621016.4:c.532-1G>C
NM_004360.3:c.532-1G>C
NM_001317184.1:c.532-1G>C
NM_001317185.1:c.-1084-1G>C
NM_001317186.1:c.-1288-1G>C
NM_004360.5:c.532-1G>C
NM_001317184.2:c.532-1G>C
NM_001317185.2:c.-1084-1G>C
NM_001317186.2:c.-1288-1G>C
NM_004360.5(CDH1):c.532-1G>C
More

Pathogenic

Met criteria codes 5
PS3 PS4 PVS1_Strong PM5_Supporting PM2_Supporting
Not Met criteria codes 6
PS2 PM6 BA1 BS2 BS3 BS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen CDH1 Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 3.1

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
CDH1 VCEP
The c.532-1G>C variant is a canonical splice variant predicted to result in a truncated or absent protein (PVS1_Strong, PM5_Supporting). This variant is present once (1/245,906 alleles) in the gnomAD v2 cohort (PM2_Supporting; http://gnomad.broadinstitute.org). Additionally, this variant has been reported in six families meeting HDGC clinical criteria (PS4; internal laboratory data). RNA analysis demonstrated that this variant results in an out-of-frame transcript, r.532_547del p.(I178Tfs*32) (PS3; internal laboratory data). In summary, this variant meets criteria to be classified as pathogenic based on the ACMG/AMP criteria applied as specified by the CDH1 Variant Curation Expert Panel (Variant Interpretation Guidelines Version 3.1): PVS1_Strong, PM2_Supporting, PS4, PS3, PM5_Supporting.
Met criteria codes
PS3
RNA analysis suggests this variant results in an out-of-frame transcript (r.532_547del p.I178Tfs*32, Ambry).
PS4
The variant has been observed in six families meeting IGCLC criteria for HDGC (Invitae, NCI, GeneDx). Eight additional families with DGC and/or LBC but who do not meet criteria for HDGC have also been observed (Invitae, Ambry, NCI).
PVS1_Strong
Canonical -1 splice site variant in intron 4, predicted to result in a truncated or absent protein. No predicted cryptic splice sites nearby.
PM5_Supporting
Application as indicated by the CDH1 splice site decision tree for variants upstream of the most 3' pathogenic variant.
PM2_Supporting
This variant occurs at a maximum subpopulation frequency of 0.00006 (1 of 16,124 alleles) in the African subpopulation and 0.000001591 (1 in 628,718 alleles) in the gnomAD v4.0.0 database.
Not Met criteria codes
PS2
The variant has not been observed de novo.
PM6
The variant has not been observed de novo.
BA1
This variant occurs at a maximum subpopulation frequency of 0.00006 (1 of 16,124 alleles) in the African subpopulation and 0.000001591 (1 in 628,718 alleles) in the gnomAD v4.0.0 database.
BS2
The variant has been observed in six families meeting IGCLC criteria for HDGC (Invitae, NCI, GeneDx). Eight additional families with DGC and/or LBC but who do not meet criteria for HDGC have also been observed (Invitae, Ambry, NCI).
BS3
RNA analysis suggests this variant results in an out-of-frame transcript (r.532_547del p.I178Tfs*32, Ambry).
BS1
This variant occurs at a maximum subpopulation frequency of 0.00006 (1 of 16,124 alleles) in the African subpopulation and 0.000001591 (1 in 628,718 alleles) in the gnomAD v4.0.0 database.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.